Medicamen Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech has filed a routine compliance certificate for the quarter ended June 30, 2025, as required under SEBI's Depositories Regulations. The company's Registrar and Share Transfer Agent, MUFG Intime India (formerly Link Intime), has confirmed that all share certificates received for dematerialization during the quarter were processed, verified, mutilated, and cancelled within the prescribed 30-day timeline. The depository's name has been duly recorded as the registered owner in the company's records. The certificate was signed by Parul Choudhary, Company Secretary (ACS-44157).
This is a standard regulatory compliance filing with no material impact on the business, financials, or share price. It simply confirms that share dematerialization activities during the quarter were handled in accordance with SEBI rules.